By Kim Pike
The CBOE last month announced the November 30th launch of the CBOE Low Volatility Index (LOVOL) – the exchange's response to risk-averse investors who are seeking smoother returns. There are some key differences among LOVOL and other so-called low volatility indexes.
For one, the LOVOL index is a 40% / 60% composite of an S&P 500 (SPY) covered-call option-and-stock strategy plus another of the “tail hedge” variety. The CBOE Holdings’ (CBOE) Chicago Board Options Exchange press release states:
"The CBOE LOVOL Index measures the performance of a portfolio that overlays SPX and CBOE Volatility Index (VIX) calls over the S&P 500 Index. Specifically, the index is obtained by holding a portfolio of S&P 500 stocks and simultaneously selling SPX calls and buying one-month VIX 30-delta calls on a monthly basis."
Are there investors out there who want this much complexity in a new low vol index?
“Many investors now are much more risk-averse than investors were in the late 1990s,” replied Matt Moran, VP Business Development at CBOE. “Two painful bear markets in stocks since 1999 have impacted investors' risk-aversion.”
Risk aversion isn't the only prompt for interest in low volatility indexes. Much has been made recently of the low volatility anomaly - the fact that many portfolios of low volatility stocks often have produced higher risk-adjusted returns than portfolios with high volatility stocks in many markets. As more studies reveal the intricacies of this anomaly, a greater number of investors have sought out lower risk through indexes such as LOVOL.
In a graph shown here from the CBOE community blog, you can see since the LOVOL’s base month of March 2006, the LOVOL has risen 38%, the S&P 500 is up 26%, and the MSCI EAFE is up 3%.

You can read more about LOVOL Index at www.cboe.com/LOVOL.
What are your thoughts on the low volatility anomaly? Have you recently sought out more risk-averse investment strategies? Leave us a comment. We love hearing from you.
Seems like an extremely
Seems like an extremely complicated product -- derivatives on top of derivatives on other derivatives based on derivatives. Trying to model or even intuitively grasp all of the factors that would affect the valuation (skew, correlation, first and second order volatility, etc) appears exceeding difficult.
Who is it aimed at? I'd think pros would rather use well-known products to get equivalent (and better understood) exposure, and retail investors would be over their head to buy it.
Post new comment